R
Roland R. Griffiths
Researcher at Johns Hopkins University School of Medicine
Publications - 422
Citations - 28262
Roland R. Griffiths is an academic researcher from Johns Hopkins University School of Medicine. The author has contributed to research in topics: Benzodiazepine & Triazolam. The author has an hindex of 81, co-authored 404 publications receiving 23367 citations. Previous affiliations of Roland R. Griffiths include University of Texas Health Science Center at Houston & University of Toronto.
Papers
More filters
Journal ArticleDOI
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance.
TL;DR: When administered under supportive conditions, psilocybin occasioned experiences similar to spontaneously occurring mystical experiences, and the ability to occasion such experiences prospectively will allow rigorous scientific investigations of their causes and consequences.
Journal ArticleDOI
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.
Roland R. Griffiths,Matthew W. Johnson,Michael A. Carducci,Annie Umbricht,William A. Richards,Brian D Richards,Mary P Cosimano,Margaret A. Klinedinst +7 more
TL;DR: High-dose psilocybin produced large decreases in clinician- and self-rated measures of depressed mood and anxiety, along with increases in quality of life, life meaning, and optimism, and decreases in death anxiety.
Journal ArticleDOI
Caffeinated energy drinks--a growing problem.
TL;DR: Several studies suggest that energy drinks may serve as a gateway to other forms of drug dependence, and regulatory implications concerning labeling and advertising, and the clinical implications for children and adolescents are discussed.
Journal ArticleDOI
Human hallucinogen research: guidelines for safety.
TL;DR: The unique history of human hallucinogens research is discussed, the risks of hallucinogen administration and safeguards for minimizing these risks are reviewed, and carefully conducted research may inform the treatment of psychiatric disorders, and may lead to advances in basic science.
Journal ArticleDOI
Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
TL;DR: When administered under supportive conditions, psilocybin occasioned experiences similar to spontaneously occurring mystical experiences that, at 14-month follow-up, were considered by volunteers to be among the most personally meaningful and spiritually significant of their lives.